PerkinElmer completes $600M purchase of Caliper

Brian Dunham | | Health Imaging | Molecular Imaging
In a transaction completed Nov. 7, PerkinElmer purchased Caliper Life Sciences for about $600 million in cash. The Hopkinton, Mass.-based imaging and detection solutions provider will operate within PerkinElmer’s newly formed Life Sciences & Technology Business entity.

PerkinElmer's Chairman and CEO Robert F. Friel said the acquisition will strengthen the company’s position in personalized medicine. Meanwhile, Caliper’s CEO Kevin Hrusovsky will lead a newly formed $500 million business that combines the former Caliper organization with PerkinElmer’s research business, according to Friel.

Brian Dunham

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.